New York State Common Retirement Fund Has $7.22 Million Position in AdaptHealth Corp. (NASDAQ:AHCO)

New York State Common Retirement Fund lifted its position in shares of AdaptHealth Corp. (NASDAQ:AHCO) by 25.0% during the 4th quarter, Holdings Channel reports. The firm owned 758,562 shares of the company’s stock after purchasing an additional 151,638 shares during the quarter. New York State Common Retirement Fund’s holdings in AdaptHealth were worth $7,222,000 as of its most recent filing with the Securities and Exchange Commission (SEC).

A number of other institutional investors and hedge funds also recently modified their holdings of AHCO. Louisiana State Employees Retirement System raised its position in shares of AdaptHealth by 30.0% in the third quarter. Louisiana State Employees Retirement System now owns 51,100 shares of the company’s stock valued at $574,000 after purchasing an additional 11,800 shares during the period. State of Alaska Department of Revenue grew its stake in AdaptHealth by 31.5% in the 3rd quarter. State of Alaska Department of Revenue now owns 60,304 shares of the company’s stock valued at $677,000 after buying an additional 14,438 shares during the last quarter. Harbor Capital Advisors Inc. raised its holdings in AdaptHealth by 142.9% in the 3rd quarter. Harbor Capital Advisors Inc. now owns 449,840 shares of the company’s stock valued at $5,052,000 after acquiring an additional 264,610 shares during the period. Amalgamated Bank lifted its position in AdaptHealth by 26.7% during the third quarter. Amalgamated Bank now owns 30,916 shares of the company’s stock worth $347,000 after acquiring an additional 6,524 shares during the last quarter. Finally, Principal Financial Group Inc. boosted its holdings in shares of AdaptHealth by 39.7% during the third quarter. Principal Financial Group Inc. now owns 543,744 shares of the company’s stock worth $6,106,000 after acquiring an additional 154,434 shares during the period. 82.67% of the stock is owned by institutional investors.

AdaptHealth Price Performance

Shares of AHCO opened at $11.10 on Thursday. The business has a 50-day moving average of $9.87 and a 200-day moving average of $10.21. The company has a debt-to-equity ratio of 1.34, a current ratio of 1.24 and a quick ratio of 1.00. The company has a market capitalization of $1.49 billion, a price-to-earnings ratio of -6.73, a price-to-earnings-growth ratio of 1.08 and a beta of 1.12. AdaptHealth Corp. has a 1 year low of $8.35 and a 1 year high of $11.90.

Analyst Ratings Changes

AHCO has been the topic of several recent research reports. Robert W. Baird lowered their price objective on AdaptHealth from $16.00 to $14.00 and set an “outperform” rating on the stock in a research report on Wednesday, November 6th. UBS Group decreased their price target on shares of AdaptHealth from $12.00 to $11.00 and set a “buy” rating on the stock in a research note on Thursday, February 13th. Truist Financial lifted their price objective on shares of AdaptHealth from $12.00 to $14.00 and gave the stock a “buy” rating in a research note on Wednesday. Canaccord Genuity Group increased their target price on shares of AdaptHealth from $13.00 to $14.00 and gave the stock a “buy” rating in a research report on Wednesday. Finally, Royal Bank of Canada raised their target price on shares of AdaptHealth from $11.00 to $14.00 and gave the stock an “outperform” rating in a report on Wednesday. Five research analysts have rated the stock with a buy rating, Based on data from MarketBeat.com, AdaptHealth currently has an average rating of “Buy” and an average target price of $13.40.

AdaptHealth Company Profile

AdaptHealth Corp., together with its subsidiaries, sells home medical equipment (HME), medical supplies, and home and related services in the United States. The company provides sleep therapy equipment, supplies, and related services, such as CPAP and bi-PAP services to individuals suffering from obstructive sleep apnea; medical devices and supplies, including continuous glucose monitors and insulin pumps for the treatment of diabetes; HME to patients discharged from acute care and other facilities; oxygen and related chronic therapy services in the home; and other HME devices and supplies on behalf of chronically ill patients with wound care, urological, incontinence, ostomy, and nutritional supply needs.